SOS2 Rabbit Polyclonal Antibody

CAT#: TA324431

Rabbit polyclonal SOS2 Antibody (N-term)

Product Images

SOS2 Antibody (N-term) (Cat. #TA324431) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the SOS2 antibody detected the SOS2 protein (arrow).

• 

  SOS2 Antibody (N-term) (Cat. #TA324431) flow cytometric analysis of HL-60 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.

Specifications

Product Data

• Applications: FC, WB
• Recommended Dilution: WB: 1:1000, FC: 1:10~50
• Reactivities: Human
• Host: Rabbit
• Isotype: IgG
• Clonality: Polyclonal
• Immunogen: This SOS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 188-215 amino acids from the N-terminal region of human SOS2.
• Formulation: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide.
• Concentration: lot specific
• Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
• Conjugation: Unconjugated
• Storage: Store at -20°C as received.
• Stability: Stable for 12 months from date of receipt.
• Predicted Protein Size: 152979 Da
• Gene Name: SOS Ras/Rho guanine nucleotide exchange factor 2
• Database Link:
  NP_008870
  Entrez Gene 20663 MouseEntrez Gene 6655 Human
  UniProt ID Q07890
• Synonyms: FLJ25596

Reference Data

• Protein Pathways: Acute myeloid leukemia, B cell receptor signaling pathway, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Dorso-ventral axis formation, Endometrial cancer, ErbB signaling pathway, Fc epsilon RI signaling pathway, Focal adhesion, Gap junction, Glioma, GnRH signaling pathway, Insulin signaling pathway, Jak-STAT signaling pathway, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pathways in cancer, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, T cell receptor signaling pathway